Evogene
在场
高管
查看带有其 23 名主要高管的组织结构图
Evogene 搜索最多的简介
- Ofer Haviv, President and Chief Executive Officer
- Sarit Firon, Chairman of the Board
- Nir Nimrodi, Board Member
高管在Compugen变化
- David SilbermanDavid Silberman 将于20248月15作为 Chief Financial Officer 加入公司 (新闻发布的2024五月16号).
- Alberto Sessa, Chief Financial Officer, 将于 20248月15 退休 (新闻发布的2024五月16号).
创建提醒
跟踪 Evogene 的高管变动
生物技术
Compugen 拥有 2,337 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
- OraSure Technologies has announced the acquisition of Sherlock Biosciences (公布2024十二月20号).
- SiteOne Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Evogene 的最新新闻稿
- Evogene Reports Third Quarter 2024 Financial Results – Evogene
- Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results – Evogene
- Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials – Evogene
- Evogene Schedules Third Quarter 2024 Financial Results Release – Evogene
- Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya – Evogene
- Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design – Evogene
- Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology – Evogene
- Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals – Evogene
- Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement – Evogene
- Evogene Reports Second Quarter 2024 Financial Results – Evogene
- View more press releases Close
通过电子邮件
